Trial · NCT00905853
Ventricular Tachycardia (VT) Ablation or Escalated Drug Therapy
NCT00905853, Phase 4, Completed, John Sapp
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Ventricular Tachycardia (VT) Ablation or Escalated Drug Therapy. Trials, record NCT00905853. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00905853
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Ventricular Tachycardia (VT) Ablation or Escalated Drug Therapy
- NCT number
- NCT00905853
- Status
- Completed
- Phases
- Phase 4
- Enrollment
- 260 participants, actual
- Lead sponsor
- John Sapp
- Conditions
- Recurrent Ventricular Tachycardia
- Interventions
- Catheter Ablation, Escalated Antiarrhythmic Therapy
- First posted
- 2009-05-21
- Last updated
- 2016-07-11
Source ClinicalTrials.gov
Registered outcomes10
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Appropriate ICD shocks,VT storm and death | 3 years | |
| Secondary | All cause mortality | 3 years | |
| Secondary | Appropriate ICD antitachycardia pacing anytime and after 1 month treatment period | 3 years | |
| Secondary | appropriate ICD shocks anytime and after 1 month treatment period | 3 years | |
| Secondary | Inappropriate shocks anytime and after 1 month treatment period | 3 years | |
| Secondary | VT storm anytime and after 1 month treatment period | 3 years | |
| Secondary | Documented sustained VT below detection rate of the ICD any time and after 1 month treatment period | 3 years | |
| Secondary | Number of ICD shocks | 3 years | |
| Secondary | Hospital admission for cardiac causes | 3 years | |
| Secondary | Procedural complications, amiodarone toxicity or adverse events | 3 years |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers2
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00905853
GET https://conductscience.org/api/trials/v1/NCT00905853/registered